Stockscreener 앱 받기
0.9914
4.36%
0.0414
시간 외 거래:
.99
-0.0014
-0.14%
전일 마감가:
$0.95
열려 있는:
$0.97
하루 거래량:
26,814
Relative Volume:
0.23
시가총액:
$43.83M
수익:
$15.97M
순이익/손실:
$-24.40M
주가수익비율:
-1.3071
EPS:
-0.7585
순현금흐름:
$-45.82M
1주 성능:
-4.67%
1개월 성능:
-3.75%
6개월 성능:
+96.32%
1년 성능:
-43.99%
1일 변동 폭
$0.956
$1.019
1주일 범위
$0.93
$1.065
52주 변동 폭
$0.50
$2.64
Elutia Inc Stock (ELUT) Company Profile
명칭
Elutia Inc
전화
240-247-1143
주소
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
0.9914 | 42.82M | 15.97M | -24.40M | -45.82M | -0.7585 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-11-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-11-02 | 개시 | Cowen | Outperform |
| 2020-11-02 | 개시 | Piper Sandler | Overweight |
| 2020-11-02 | 개시 | Truist | Buy |
Elutia Inc 주식(ELUT)의 최신 뉴스
Elutia (ELUT) grants director Kevin Rakin 159,590 stock options - Stock Titan
Elutia (NASDAQ: ELUT) director awarded 106K stock options as compensation - Stock Titan
Elutia (NASDAQ: ELUT) director receives 106,393 stock options at $0.96 strike - Stock Titan
Elutia (NASDAQ: ELUT) director Brigid Makes receives 106,393-share stock option grant - Stock Titan
ELUT Q1 2026 Earnings: EPS Misses Estimates, Stock Ticks UpNext Quarter Guidance - newsline.com
ELUT Q1 2026 Earnings: EPS Misses Estimates, Stock Edges Higher Despite SurpriseShare Dilution Risk - newsline.com
ELUTIA (ELUT) CSO reports RSU vesting and tax withholding share disposition - Stock Titan
Elutia (ELUT) CFO reports RSU vesting and tax withholding event - Stock Titan
Elutia (ELUT) CEO RSUs vest; shares withheld to cover taxes - Stock Titan
Elutia to Present at Planet MicroCap Showcase 2026 on June 17th - BioSpace
Breast reconstruction infections: Elutia to outline biomatrix tech in Vegas - Stock Titan
Elutia Inc. (ELUT) Q1 2026 Earnings: Wider-Than-Expected Loss Weighs on SharesMargin Guidance - newsline.com
Elutia Inc. (ELUT) Edges Higher: Approaching Resistance Amid Low-Volume RallyRectangle Pattern - newsline.com
Elutia Inc. (ELUT) Edges Higher: Stock Gains 3.49% as Price Approaches Key ResistanceEqual Weight ETF - newsline.com
Elutia Inc. (ELUT) Slips Nearly 5% as Stock Tests Key Support LevelsDescending Triangle - newsline.com
Despite Elutia's Pullback, Insiders Still Gained US$75k - simplywall.st
Elutia (ELUT) director gifts shares and updates trust, HighCape stakes - Stock Titan
ELUT Q1 2026 Earnings: EPS Misses Estimates as Stock Declines Nearly 7%Peak Earnings Alert - newsline.com
ELUT Q1 2026 Earnings: EPS Misses Estimates on Higher Operating CostsDownward Estimate Revision - newsline.com
Elutia Inc. (ELUT) Holds Near Key Support After Marginal DeclineChannel Projection - newsline.com
Elutia Stock Flat Ahead of Open as $1.5 Billion Decision Waits - Bez Kabli
Elutia Inc. (ELUT) Slips 3.33% as Stock Tests Key Support LevelsStop Run - The Legal Advocate
Elutia Inc. (ELUT) Dips 3.33% as Stock Hovers Near Critical $1.10 SupportRevenue Growth Stocks - Newser
A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching - GlobeNewswire
ELUT Q1 2026 Earnings: EPS Misses Estimates as Stock Moves HigherPro Trader Picks - Newser
Elutia (ELUT) Q1 2026 Earnings Miss by Significant: Key TakeawaysEarnings Seasonality - thelegaladvocate.com
Elutia (ELUT) Q1 2026 Results: Profit Pressure, Guidance CutPost-Earnings Reaction - Newser
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - Sahm
Elutia (ELUT) Q1 2026 Earnings Miss: EPS $-0.17 vs $-0.15 ExpectedDownward Estimate Revision - The Legal Advocate
ELUT: Antibiotic-eluting matrix targets high breast reconstruction infection rates in a $1.5B market - TradingView
Is Elutia (ELUT) Overvalued After Q1 2026? EPS Not Disclosed; Re - GuruFocus
Elutia (ELUT) Q1 2026 Earnings Transcript - AOL.com
Elutia (NASDAQ: ELUT) posts wider Q1 2026 loss while holding $28.5M cash - Stock Titan
About Us | Oil & Gas JournalElutia, Inc.Class A Common Stock (Nasdaq:ELUT) Stock Quote - FinancialContent
Elutia Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:ELUT) 2026-05-15 - Seeking Alpha
Elutia Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Elutia to Present at the 16th Annual LD Micro Invitational on May 18th - Sahm
Elutia Inc (ELUT) Q1 2026 Earnings Call Highlights: Strategic Ad - GuruFocus
Number of shareholders of Elutia, Inc. – NASDAQ:ELUT - TradingView
Lake Street Maintains Elutia(ELUT.US) With Buy Rating, Maintains Target Price $5 - Moomoo
Transcript : Elutia Inc., Q1 2026 Earnings Call, May 14, 2026 - marketscreener.com
ELUT: Q1 2026 delivered revenue growth, margin gains, and strategic progress toward NXT-41x launch - TradingView
Elutia Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Elutia’s Q1 2026 earnings miss EPS, revenue exceeds forecast - Investing.com
Elutia earnings missed by $0.02, revenue topped estimates - Investing.com Canada
Elutia Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Elutia 1Q Loss $7.47M >ELUT - Moomoo
Elutia reports Q1 results, expects FDA clearance for NXT-41 By Investing.com - Investing.com South Africa
Elutia : Presentation (ELUT Earning Call 14May26 Final) - marketscreener.com
Elutia reports Q1 results, expects FDA clearance for NXT-41 - Investing.com
ELUTIA ($ELUT) Releases Q1 2026 Earnings - Quiver Quantitative
Elutia Inc (ELUT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Elutia Inc 주식 (ELUT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| NEELS GUIDO J | Director |
Jan 30 '26 |
Buy |
1.04 |
20,000 |
20,800 |
118,750 |
| NEELS GUIDO J | Director |
Jan 29 '26 |
Buy |
1.06 |
15,000 |
15,900 |
98,750 |
| NEELS GUIDO J | Director |
Jan 28 '26 |
Buy |
1.06 |
15,000 |
15,900 |
83,750 |
2.43%
자본화:
|
볼륨(24시간):